Discover
NNNN
Anbio Biotechnology
5.25
1 x 11.55
1 x 9.89
bid
ask
-
0.35
6.25%
1 @ 07:57 PM
5.27 +0.02 (0.38%)
| Ytd | -82.54% | |
| 1y | -87.62% |
5.13
day range
5.66
5.25
52 week range
42.59
| Open | 5.64 | Prev Close | 5.60 | Low | 5.13 | High | 5.66 | Mkt Cap | 230.43M |
| Vol | 290.24K | Avg Vol | 134.06K | EPS | 0.15 | P/E | 35.00 | Forward P/E | N/A |
| Beta | 5.17 | Short Ratio | 1.79 | Inst. Own | 4.90% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-28 | 50-d Avg | 8.61 | 200-d Avg | 21.72 | 1yr Est | 0.00 |
| Income Statement | |||
| Weighted Average Shares | 43.67M | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.77M | ||
| Cash and Equivalents (USD) | 7.77M | ||
| Investments | 4.13M | ||
| Investments Current | 4.13M | ||
| Trade and Non-Trade Receivables | 3.66M | ||
| Current Assets | 30.24M | ||
| Total Assets | 30.24M | ||
| Current Liabilities | 87.84K | ||
| Total Liabilities | 87.84K | ||
| Accumulated Retained Earnings (Deficit) | 23.58M | ||
| Shareholders Equity | 30.16M | ||
| Shareholders Equity (USD) | 30.16M | ||